Exponential Moving Averages (EMA): The exponential moving averages confirm the bullish MA structure. The EMA_5 ($235.57) is above the EMA_10 ($232.91), which is above the EMA_20 ($231.01). The price is above all three EMAs, suggesting sustained buying momentum.

MACD (Moving Average Convergence Divergence): The MACD line is at 1.5581, significantly above the signal line (MACDS) at 0.1099, resulting in a large positive histogram (MACDH) of 1.4482. This is a strong bullish signal, indicating that the short-term momentum is accelerating upwards relative to the longer-term trend. The widening histogram suggests increasing bullish pressure.

RSI (Relative Strength Index): The 14-period RSI is at 63.15. This places the indicator in the “bullish” zone (above 50) but below the overbought threshold of 70, suggesting there is room for further price appreciation before becoming technically extended. The more sensitive RSI_6 is at 76.58, which is in the overbought region, indicating that the very short-term move has been strong and may be due for a minor consolidation or pullback.

Bollinger Bands: The current close ($238.33) is trading just below the Upper Band ($239.50). Trading near the upper band suggests the stock is in a strong uptrend. The Middle Band (20-day SMA) at $230.30 acts as dynamic support. The width of the bands (Upper $239.50 - Lower $221.10 = $18.40) indicates moderate volatility.

KDJ Indicator: The KDJ readings show K (79.34) and D (67.91) in bullish territory, while the J value (102.22) is above 100, signaling an overbought condition on this oscillator. This aligns with the RSI_6 reading and suggests the near-term rally may be overextended, warranting caution for new entries at current levels.

Other Indicators:

• ATR (Average True Range): At $4.50, it quantifies the current daily volatility, which is useful for setting stop-loss levels.
• Williams %R: At -15.75, it is in the “overbought” zone (typically below -20), reinforcing the short-term overbought signals from RSI_6 and KDJ.
• CCI (Commodity Channel Index): At 143.95, it is well above the +100 threshold, indicating strong upward trend momentum.
• ADX (Average Directional Index): At 21.29, it suggests a weak to moderate trend strength. A reading above 25 is generally considered the start of a strong trend.
• MFI (Money Flow Index): At 0.56, this value appears to be an error or misinterpretation, as MFI typically ranges from 0 to 100. This data point should be disregarded for analysis.

📉 Price Trend Analysis

Recent Price Action: Analyzing the provided 60-day data, Johnson & Johnson (JNJ) experienced a significant decline from late April to early May 2026, bottoming around $220.63 on 2026-05-07. Since that low, the stock has staged a robust recovery. The last five trading days show a clear upward trajectory: $232.77 -> $232.16 -> $237.00 -> $238.49 -> $238.33. The breakout above the $235 level on 2026-06-09 was a significant technical event, confirmed by above-average volume of 8.35 million shares.

Support and Resistance Levels:

• Immediate Resistance: The Upper Bollinger Band at $239.50 and the recent high of $241.60 (2026-06-11) form the first key resistance zone. A decisive break above $241.60 could target the April highs near $245.
• Immediate Support: The most immediate support is the cluster of moving averages between $230.19 (MA_10) and $232.32 (MA_60). This zone should hold to maintain the bullish structure.
• Secondary/Strong Support: The next major support lies in the $224 - $225 area, which was the consolidation zone in late May and aligns with the Lower Bollinger Band ($221.10).
• Major Support: The significant low from May at $220.63 is critical long-term support. A break below this level would invalidate the current recovery thesis.

Volume Analysis: Volume has been supportive of the recent uptrend. The rally day on 2026-06-09 saw volume of 8.35 million shares, well above the levels seen during the preceding consolidation. The volume on 2026-05-29 (13.72 million shares) was exceptionally high on a down day, potentially indicating a capitulation or significant distribution event that may have marked a near-term low. Recent volume, while not explosive, has been adequate to fuel the price rise, suggesting genuine buying interest rather than a short squeeze alone.

Chip Distribution Analysis (Estimated):

• Methodology Note: The provided chip distribution is an estimate based on statistical analysis of historical OHLC (Open, High, Low, Close) and turnover data. It models where trading volume has been concentrated to infer an average cost basis for market participants. It is not actual shareholder position data from the exchange.
• Interpretation: As of 2026-06-11, the estimated profit ratio is 77.83%, meaning a large majority of chips held are in a profitable position. The average cost is estimated at $231.77, which is below the current price ($238.33). The 70% cost concentration range is narrow ($225.30 to $239.31, span of $14.01), and the 90% range is also relatively tight ($222.60 to $240.39, span of $17.79). This suggests a high degree of cost consensus among market participants. The current price is near the top of the 70% range, which can act as a psychological resistance area as profits are taken. However, a successful breakout above $240 could trigger further buying as it would push the price above a significant cost concentration zone.

💭 Investment Recommendations

Technical Outlook: The technical picture for Johnson & Johnson (JNJ) has shifted to bullish in the short-to-medium term. The recovery from the May lows has been strong, supported by positive alignments in moving averages, a robust MACD signal, and price action breaking above previous resistance. The trend is your friend, and the trend is currently up.

Recommendation: HOLD with a bias towards ADDING ON WEAKNESS for existing investors. CAUTION for new buyers at current levels.

Rationale:

1. For Existing Holders: The bullish MA and MACD configurations support maintaining positions. The stock is in a clear recovery phase. Consider holding core positions and using any pullback towards the key support zone ($230-$232) to add to positions.
2. For New Buyers: While the trend is positive, several short-term oscillators (RSI_6, KDJ, Williams %R) are flashing overbought signals. Entering at the current price, near the Bollinger Upper Band and recent highs, carries a higher risk of an immediate pullback. A more prudent strategy would be to wait for a pullback to the support zone ($230-$232) or a decisive daily close above the $241.60 resistance for a confirmed breakout before initiating new long positions.

Key Risk Warnings:

1. Overbought Short-Term Condition: The stock is exhibiting overbought signals on multiple short-term momentum indicators. This increases the probability of a consolidation or minor pullback in the coming sessions.
2. Resistance Test: The price is testing a confluence of resistance near $239.50-$241.60. Failure to break through could lead to a reversal.
3. Market Risk: This analysis is purely technical. Johnson & Johnson is a fundamental company, and its stock can be impacted by broader market sentiment, interest rate changes, regulatory news, or company-specific developments (e.g., litigation, drug pipeline updates) not captured in price charts.
4. Chip Distribution Limitation: The chip analysis is an estimate. Real buying and selling pressure can deviate from this model, especially around major news events.
5. Stop-Loss Consideration: Investors with a short-term horizon should consider a stop-loss order below the $230 support level (e.g., $229) to protect capital in case the bullish structure fails. The Average True Range (ATR) of $4.50 can help gauge an appropriate stop distance.

Price Targets:

• Upside: A sustained break above $241.60 could open the path towards the April resistance area around $245. The next significant target would be the yearly high.
• Downside: A break below the $230 support cluster would signal weakness and could lead to a retest of the $224-$225 support zone. A breach of $220.63 would be a strongly bearish development. ✅ Analysis Complete